Health Management

Research Shows Increase of Americans with Uncontrolled High Blood Pressure

September 14, 2020

The American Medical Association and American Heart Association reaffirm commitment to working together to equip physicians and all Americans, particularly communities of color, with resources to lower blood pressure rates across the country.

CareMount Medical President and CEO Scott Hayworth Talks Patient, Doctor Communication to Reduce Health Risks and Prevent Missed, Delayed Screenings

August 19, 2020

This week on Tuning Into The C-Suite Briana Contreras spoke with Dr. Scott Hayworth, president and CEO of New York-based CareMount Medical. In this interview, the two discussed the importance of patients staying in contact with their doctors for the sake of reducing public health risks and to discuss ongoing care options with them.

An Update for Cardiologists Who See Patients With Type 2 Diabetes

August 05, 2020

The American College of Cardiology issues its second set of recommendations for its members on prescribing two groups of drugs first developed for type 2 diabetes.

Upping the Cardiovascular Health Game

August 01, 2020

COVID-19 spotlights the threat that cardiovascular disease poses to Americans; new technology may help address risk factors at the population health level.

Tips for Keeping Health Workers Safe

July 24, 2020

Jagdish Khubchandani, a Health Science professor at Ball State University, provides tips and reminders to help keep one of the most vulnerable populations safe during the continuous battle of COVID-19.

Tackling Diabetes While Curbing Costs

July 23, 2020

Three healthcare organizations provide models for managing the disease and keeping a close eye on the bottom line.

Eric Levin talks PBMs and how Scripta is Tackling the Market's Challenges for Patients

July 22, 2020

MHE's Briana Contreras spoke with CEO of Scripta, Eric Levin. The two discussed the current state of the pharmacy benefit market and how the Scripta organization has been assisting its clients and their prescriptions prior to the COVID-19 pandemic and during.

Jim Beiermann, Danny Irland of Southwestern Health Resources Talk ACO, Next Gen. Programs (Pt. 2)

July 11, 2020

Jim Beiermann, CFO, and Danny Irland, senior vice president of network operations and chief network officer of Southwestern Health Resources discuss their focus of value-based care through ACO and Next Generation Programs within the company with Managed Healthcare Executive Senior Editor, Peter Wehrwein.

TRHC Expands Clinical Services to Include MA Enrolled High-Risk, Special Needs Patients

July 10, 2020

The healthcare tech company will assist health plans in meeting Care for Older Adults requirements.

Jim Beiermann, Danny Irland of Southwestern Health Resources Talk ACO, Next Generation Programs (Pt. 1)

July 10, 2020

Jim Beiermann and Danny Irland, both of Southwestern Health Resources, discuss their focus of value-based care through ACO and Next Generation Programs.

Convergence of Dental, Health Insurance Increases

July 02, 2020

Of the 87% of executives who see convergence already happening, 89% say it is accelerating—up from 21% who said the same in 2018.

CT Scans for Diagnosing COVID-19? Not So Much.

June 23, 2020

Early studies from China suggested that CT scans of the lungs could be used to diagnose the disease. But as PCR tests became available, radiology groups said CT scans should be used more sparingly and in confirmed cases.

Flatiron Health's Bobby Green Outlines Cancer Clinical Trial to Understand Genomic Changes in Tumors (Pt. 4)

June 22, 2020

During the American Society of Clinical Oncology 2020 Annual Meeting, Flatiron Health, Foundation Medicine, and Genentech presented plans for the Prospective Clinico-Genomic study (PCG), a low-interventional pilot that will use a technology-enabled prospective data collection platform to simplify data collection for patients with lung cancer being treated through clinical trials. The idea is collect blood samples using Foundation Medicine’s liquid biopsy assay and analyze the results through Flatiron’s platform, to see if genomic changes can be detected over the course of cancer treatment. Bobby Green, MD, chief medical officer for Flatiron Health, spoke with Managed Healthcare Executive®.

High Hopes for Inclisiran. Will the Third Time be the Charm for PCSK9 Inhibition?

June 22, 2020

The two PCSK9 inhibitors have fallen far short of expectations. Inclisiran, which works by RNA inference, only needs to be injected twice a year. 

4 Ways PBMs are Changing

June 22, 2020

Pharmacy benefit managers are taking steps to be more responsible for the total cost of care and to become more transparent, while adding technology tools to support patients, payers and physicians in a post-COVID-19 world.

What to Expect from CMS’ response to COVID-19

June 19, 2020

As the pandemic enters its fourth month in the U.S., the Center for Medicare and Medicaid Innovation (the Innovation Center) has announced several changes that, on the whole, increase flexibility for program participants.

At-Home Pulse Oximeters: The ‘It’ Gadget of the COVID-19 Outbreak

June 19, 2020

Early detection of low blood oxygen levels may detect ‘silent hypoxia’ seen in some patients with COVID-19. But the American Lung Association advises against buying a pulse oximeter unnecessarily.

Healthcare Leaders Form Taskforce on Telehealth

June 18, 2020

Will produce recommendations for policymakers on crucial issues for future of remote care services.

Covid-19 Hit: Picking Up the Pieces of American Healthcare

June 18, 2020

Some hospitals were overwhelmed. But for many providers, COVID-19 has meant the absence of patients - and major drops in revenue. And now there is a possible economic downturn. COVID-19 has hit American healthcare and hit it hard.   

DataGen's John Kalamaras Discusses Changes in BPCI Advanced

June 17, 2020

John Kalamaras, business intelligence analytics manager of DataGen, chats with Managed Healthcare Executive's Briana Contreras, about the Centers for Medicare and Medicaid Services, or CMS’, recent announcement of the changes they’ve made for participants in their value-based programs, specifically those in bundled-care programs like BPCI Advanced, whose episodes were affected by COVID-19.